Elan Board Rejects Royalty Pharma's Latest Offer

Following the denial of an acquisition offer from Royalty Pharma on April 22 equal to $11.25 a share, or less, for all of Elan's (UNKNOWN: ELN.DL2  ) outstanding shares, a revised offer from Royalty of $12.50 a share has also been rejected, Elan announced today.

In its statement, Elan commented that the reason the board of directors unanimously agreed to reject Royalty's bid was because it "substantially undervalues the company." Elan shareholders will receive a circular and a notice of an "Extraordinary General Meeting (EGM)" that will be held on June 17, 2013. Until the EGM is held, Elan shareholders are, "strongly and unequivocally advised to take no action" on Royalty's acquisition offer, according to the press release.

In response to Royalty's bid, Elan chairman of the board Robert Ingram said, "This offer is no more than an opportunistic attempt to acquire our company at a substantial discount at our Shareholders' expense."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2451139, ~/Articles/ArticleHandler.aspx, 11/20/2014 10:04:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement